The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review

Number of illness episodes as predictor of residual symptoms in major depressive disorder

(2018) Gianluca Serafini et al.   PSYCHIATRY RESEARCH

Eight-Milligram Single Dose of Buprenorphine as an Expeditious Treatment for Severe Suicidal Ideation: A Case Report

(2017) Jamshid Ahmadi et al.   Iranian Red Crescent Medical Journal

Long-Term Impact of Residual Symptoms in Treatment-Resistant Depression

(2017) Abebaw Fekadu et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Buprenorphine and the treatment of depression, anxiety, non-suicidal self-injury, and suicidality

(2016) L. Sher   ACTA PSYCHIATRICA SCANDINAVICA

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial

(2016) Maurizio Fava et al.   AMERICAN JOURNAL OF PSYCHIATRY

Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial

(2016) Yoram Yovell et al.   AMERICAN JOURNAL OF PSYCHIATRY

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2016) Theo Vos et al.   LANCET

Single- and Multiple-dose Pharmacokinetics of Samidorphan, A Novel Opioid Antagonist, in Healthy Volunteers

(2015) Ryan Turncliff et al.   CLINICAL THERAPEUTICS

BU08073 a buprenorphine analogue with partial agonist activity at μ-receptorsin vitrobut long-lasting opioid antagonist activityin vivoin mice

(2014) T V Khroyan et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

(2014) Gianluca Serafini et al.   Current Neuropharmacology

The Anti-Suicidal Potential of Buprenorphine: A Case Report

(2014) Joan M. Striebel et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE

Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults

(2014) Jordan F. Karp et al.   JOURNAL OF CLINICAL PSYCHIATRY

Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

(2014) Elizabeth D. Ballard et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Evaluation of Opioid Modulation in Major Depressive Disorder

(2014) Elliot Ehrich et al.   NEUROPSYCHOPHARMACOLOGY

Biological substrates underpinning diagnosis of major depression

(2013) Etienne Sibille et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Prescription Opioid Analgesics Increase the Risk of Depression

(2013) Jeffrey F. Scherrer et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Opioid receptors: distinct roles in mood disorders

(2012) Pierre-Eric Lutz et al.   TRENDS IN NEUROSCIENCES

Endogenous opiates and behavior: 2010

(2011) Richard J. Bodnar   PEPTIDES

Why Does Depression Hurt? Ancestral Primary-Process Separation-Distress (PANIC/GRIEF) and Diminished Brain Reward (SEEKING) Processes in the Genesis of Depressive Affect

(2011) Jaak Panksepp et al.   PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES

The delta opioid receptor: an evolving target for the treatment of brain disorders

(2011) Amynah A. Pradhan et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse

(2010) Sunmee Wee et al.   PSYCHOPHARMACOLOGY

Dynorphin, stress, and depression

(2009) Allison T. Knoll et al.   BRAIN RESEARCH

Opiates as Antidepressants

(2009) Esther Berrocoso et al.   CURRENT PHARMACEUTICAL DESIGN

Reward Processing by the Opioid System in the Brain

(2009) Julie Le Merrer et al.   PHYSIOLOGICAL REVIEWS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Opiate Treatment in Depression Refractory to Antidepressants and Electroconvulsive Therapy

(2008) Peter W. Nyhuis et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

(2008) IM Anderson et al.   JOURNAL OF PSYCHOPHARMACOLOGY